AEPCX
Price
$58.34
Change
+$0.18 (+0.31%)
Updated
Jun 6 closing price
Net Assets
133.45B
FADIX
Price
$28.63
Change
+$0.10 (+0.35%)
Updated
Jun 6 closing price
Net Assets
1.52B
Interact to see
Advertisement

AEPCX vs FADIX

Header iconAEPCX vs FADIX Comparison
Open Charts AEPCX vs FADIXBanner chart's image
American Funds EUPAC C
Price$58.34
Change+$0.18 (+0.31%)
VolumeN/A
Net Assets133.45B
Fidelity Advisor Diversified Intl M
Price$28.63
Change+$0.10 (+0.35%)
VolumeN/A
Net Assets1.52B
AEPCX vs FADIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. FADIX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and FADIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. FADIX (1.52B). FADIX pays higher dividends than AEPCX: FADIX (1.17) vs AEPCX (0.32). AEPCX was incepted earlier than FADIX: AEPCX (24 years) vs FADIX (26 years). AEPCX (1.59) is less costly to investors than FADIX (1.37). FADIX is a more actively managed with annual turnover of: 33.00 vs. AEPCX (30.00). FADIX has a lower initial minimum investment than AEPCX: FADIX (0) vs AEPCX (250). FADIX annual gain was more profitable for investors over the last year : 6.99 vs. AEPCX (1.93). FADIX return over 5 years is better than : 23.27 vs. AEPCX (14.63).
AEPCXFADIXAEPCX / FADIX
Total Expense Ratio1.591.37116%
Annual Report Gross Expense Ratio1.591.37116%
Fund Existence24 years26 years-
Gain YTD12.90916.49778%
Front LoadN/A4%-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets133B1.52B8,773%
Annual Yield % from dividends0.321.1728%
Returns for 1 year1.936.9928%
Returns for 3 years14.7424.1061%
Returns for 5 years14.6323.2763%
Returns for 10 years21.4442.5850%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OBIO3.310.26
+8.52%
Orchestra BioMed Holdings
SES1.040.07
+6.97%
SES AI Corp
ENVB1.300.04
+3.17%
Enveric Biosciences Inc
TMDX139.053.46
+2.55%
TransMedics Group
REXR36.030.48
+1.35%
Rexford Industrial Realty